• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068505110
Device Problems Defective Device (2588); Material Twisted/Bent (2981); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Erosion (1750); Pain (1994); Scarring (2061); No Code Available (3191)
Event Date 06/16/2016
Event Type  Injury  
Manufacturer Narrative
Date of event: date of event was approximated to (b)(6) 2016, device implantation date, as no event date was reported.(b)(4).This was reported by the patient's lawyer.The device was implanted by dr.(b)(6) at (b)(6) hospital.The surgical intervention was performed by dr.(b)(6).The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo was implanted during a trans-obturator tape mid-urethral sling and cystoscopy procedure performed on (b)(6) 2016 to treat stress urinary incontinence.A concomitant procedure for anterior and posterior prolapse repair was also performed by a different physician to treat pelvic organ prolapse.The procedure completed without complications.According to the complainant, after the procedure, the patient experienced vaginal pain, pain during intercourse, muscular groin pain, and leg pain.Subsequently, on (b)(6) 2017, removal of the vaginal sling, removal of vulvar mesh with exploration of the obturator space, urethral lysis, vaginal paravaginal, dissection and mesh removal from the deep obturator internus muscles, removal from the adductor muscles, and anterior colporrhaphy were performed under endotracheal anesthesia.During this surgery, in addition to pain, urethral scarring was also identified.The scar tissue was dissected cephalad, caudad, and laterally.The urethral lysis was performed using sharp dissection to further free the scar tissue.Then, the mesh was fully excised.The entire obtryx ii tot sling was removed.The patient reportedly tolerated the surgery well and was in excellent condition following the surgery.
 
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo was implanted during a trans-obturator tape mid-urethral sling and cystoscopy procedure performed on (b)(6) 2016 to treat stress urinary incontinence.A concomitant procedure for anterior and posterior prolapse repair was also performed by a different physician to treat pelvic organ prolapse.The procedure completed without complications.According to the complainant, after the procedure, the patient experienced vaginal pain, pain during intercourse, muscular groin pain, and leg pain.It was also reported that there was presence of "foreign material" in the patient's vagina.Subsequently, on (b)(6) 2017, removal of the vaginal sling, removal of vulvar mesh with exploration of the obturator space, urethral lysis, vaginal paravaginal, dissection and mesh removal from the deep obturator internus muscles, removal from the adductor muscles, and anterior colporrhaphy were performed under endotracheal anesthesia.During this surgery, in addition to pain, urethral scarring was also identified.The scar tissue was dissected cephalad, caudad, and laterally.The mesh was identified and noted to be at the bladder neck and corded/rolled/banded.It was cut in the midline and freed from the vaginal scar tissue on the left and the right.The urethral lysis was performed using sharp dissection to further free the scar tissue.Then, the mesh was fully excised.The entire obtryx ii tot sling was removed.The patient reportedly tolerated the surgery well and was in excellent condition following the surgery.
 
Manufacturer Narrative
Block b3: date of event: date of event was approximated to (b)(6) 2016, device implantation date, as no event date was reported.Blocks f10 and h6: patient code 1750 captures the reportable event of "foreign material" in the vagina.Patient code 3191 captures the reportable event of the surgery to address the patient issues.Patient code 1994 captures the reportable event of pain.Patient code 2061 captures the reportable event of urethral scarring.Device code 2588 captures the reportable event of mesh at the bladder neck.Block e1: this was reported by the patient's lawyer.The device was implanted by dr.(b)(6) at (b)(6) hospital.The surgical intervention was performed by dr.(b)(6).Block h6: conclusion code 4316 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: blocks b5, g3 report source, and f10/h6 patient and device codes updated to provide the correct information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX II SYSTEM - HALO
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key8720829
MDR Text Key148756834
Report Number3005099803-2019-03081
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729837565
UDI-Public08714729837565
Combination Product (y/n)N
PMA/PMN Number
K121754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 08/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/25/2019
Device Model NumberM0068505110
Device Catalogue Number850-511
Device Lot Number0000029116
Was Device Available for Evaluation? No
Date Manufacturer Received07/15/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-